Spinal Cord Stimulator Litigation News
Pre-MDL Consolidation · 2025–2026

Spinal Cord Stimulator Litigation:
Consolidation Efforts Grow as Injury Reports Rise

Lawsuits against Medtronic, Boston Scientific, Abbott/St. Jude, and Nevro are multiplying across federal and state courts. National mass-tort trackers list SCS litigation as “pending consolidation” — MDL formation is expected. Our firm is accepting cases nationwide.

Spinal cord stimulators are implanted devices used to treat chronic pain — but thousands of patients have reported severe complications including nerve damage, electric shocks, burns, device migration, lead failure, and repeated revision surgeries. Plaintiffs allege that major manufacturers sold defectively designed devices and failed to adequately warn patients and physicians, even as FDA adverse-event reports mounted into the thousands.
4 Major manufacturers named as defendants
1,000s FDA adverse-event reports in MAUDE database
Pending MDL consolidation listed on national trackers
Active Common-issue discovery push underway

Named Defendants

Which Manufacturers Are Being Sued?

Lawsuits have been filed against all four major spinal cord stimulator manufacturers. Plaintiffs allege defective leads, battery failures, generator malfunctions, and inadequate warnings across product lines sold under several brand names.

MedtronicLargest SCS manufacturer
Boston ScientificPrecision & WaveWriter lines
Abbott / St. JudeProclaim & Eon lines
NevroHF10 & Senza lines

What Plaintiffs Allege

How These Devices Failed Patients

Plaintiffs allege a pattern of device defects and corporate failures that left patients with injuries far worse than the chronic pain the devices were meant to treat.

Defective Leads

Lead wires fracture, migrate, or degrade, delivering uncontrolled electrical impulses or failing to deliver therapy — causing nerve damage and requiring removal surgery.

Electric Shocks & Burns

Patients report sudden, painful shocks and tissue burns from malfunctioning devices, including during sleep or routine activity.

Device Migration

Stimulator leads shift from their implanted position, reducing effectiveness and causing new areas of pain or neurological injury.

Battery & Generator Failure

Premature battery depletion and generator malfunctions require additional surgeries to replace components — each procedure carrying its own risk of complications.

Infection

Implant-site infections linked to device failure or inadequate device materials have required antibiotic treatment, surgical debridement, or full device removal.

Inadequate Warning

Plaintiffs allege manufacturers were aware of failure rates through internal complaint data and FDA MAUDE reports but failed to update labeling or warn surgeons and patients.

Procedural Posture · 2025–2026

Where the Litigation Stands Now

SCS litigation is in the pre-MDL growth phase, with consolidation efforts and common-issue discovery ramping up across multiple federal districts. National mass-tort trackers list the litigation as “pending” for MDL centralization — a status that reflects overlapping federal filings and growing pressure for formal coordination.

Now Case-Specific Discovery

Early-stage discovery underway in scattered federal and state cases. Plaintiffs are building individual case records while simultaneously pushing for common-issue discovery protocols.

Active Common-Issue Discovery Push

Plaintiffs are seeking design files, internal complaint data, MAUDE adverse-event reports, and manufacturer training materials — even before formal MDL creation.

Backdrop FDA MAUDE Database

Thousands of adverse-event reports in the FDA’s MAUDE database are cited in complaints to establish product defect and manufacturer notice.

Expected MDL Consolidation

With multiple overlapping federal filings and growing case volume, a JPML petition for MDL centralization is widely anticipated among mass-tort practitioners.

Filing now matters. Pre-MDL cases often receive more individual attention and may be positioned as bellwether candidates once consolidation occurs. Early claimants can influence how the MDL develops.

Eligibility

Common Injuries Linked to Spinal Cord Stimulators

You may qualify if you received a spinal cord stimulator from one of the named manufacturers and subsequently experienced complications requiring additional medical treatment.

Qualifying Injuries

  • Nerve damage or neurological injury
  • Electric shocks from the device
  • Burns at or near the implant site
  • Device or lead migration
  • Lead fracture or failure
  • Infection or abscess
  • Revision or removal surgery
  • Loss of mobility or function

General Eligibility Factors

  • Received an SCS device from Medtronic, Boston Scientific, Abbott/St. Jude, or Nevro
  • Experienced one or more qualifying complications after implantation
  • Complication documented in medical or surgical records
  • Required additional medical treatment due to device failure

Our Firm Is Now Accepting Spinal Cord Stimulator Cases

We represent patients nationwide harmed by defective spinal cord stimulators and aggressively pursue compensation for medical costs, revision surgeries, pain, and disability. We track every development in SCS litigation — from common-issue discovery to MDL consolidation proceedings — to ensure our clients are best positioned for recovery.

We handle these cases on a contingency fee basis — you pay nothing unless we win.

This page is for informational purposes only and does not constitute legal advice. Results in prior cases do not guarantee similar outcomes. Consult a qualified attorney for advice specific to your situation.
Our Firm Is Now Accepting Spinal Cord Stimulator Cases Free & confidential case evaluation — you pay nothing unless we win.
Get Your Free Case Evaluation